Clinical Trial Update: Shanghai Lymphoma Clinical Cohort

View source ↗

Summary

This clinical trial update reports a Shanghai-based lymphoma cohort study sponsored by Ruijin Hospital that is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Snippet

Sponsor: Ruijin Hospital | Conditions: Lymphoma, Cohort | Status: NOT_YET_RECRUITING